Janos Z.
- Country
- Hungary
- Department
- Obstetrics and Gynecology
Research Overview
- Evaluation of Contraceptive Efficacy, Safety and Tolerability of Oral Drospirenone 4 mg (LPRI‑CF113) Over 13 Cycles: Multicentre Open‑Label Single‑Arm Study
- Efficacy of Vitex agnus-castus BNO 1095 in the Management of Primary Dysmenorrhea in Women: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
Data & Insights
Has run more than one trial at 30 of 246 partner sites.
Specializations
Endometriosis and Pelvic Pain
Janos Zatik is involved in clinical research focused on endometriosis-related pain, with attention to the control of overall pelvic pain and symptom relief in women of reproductive age.
- Endometriosis-related pain
- Overall pelvic pain
- Women’s pain management
This area reflects a therapeutic interest in improving comfort and daily functioning for patients affected by chronic gynecological pain.
Menstrual Disorders
His research landscape includes studies in primary dysmenorrhea, addressing cramping pain associated with menstruation and the need for symptom-focused treatment options.
- Primary dysmenorrhea
- Menstrual cramping pain
- Gynecologic symptom relief
The clinical focus in this domain centers on therapies aimed at reducing menstrual pain and improving cycle-related well-being.
Menopausal Vasomotor Symptoms
Janos Zatik is also engaged in research on moderate to severe vasomotor symptoms, including hot flashes linked to adjuvant endocrine therapy in women with hormone receptor-positive breast cancer.
- Vasomotor symptoms
- Hot flashes
- Breast cancer endocrine therapy
This therapeutic area involves symptom control in patients managing treatment-related menopausal effects.
Contraception and Reproductive Health
His trial activity includes work on pregnancy prevention and the evaluation of contraceptive performance, with interest in the safety and tolerability of levonorgestrel-based vaginal delivery systems.
- Pregnancy prevention
- Contraceptive efficacy
- Levonorgestrel vaginal delivery system
This area supports development of contraceptive options within women’s reproductive healthcare.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.